# Survival and Recurrence After ABO-Incompatible Living Donor Liver Transplantation for Hepatocellular Carcinoma

> **NCT07703735** · — · ENROLLING_BY_INVITATION · sponsor: **Seoung Hoon Kim** · enrollment: 371 (estimated)

## Conditions studied

- Liver Transplantation
- Hepatocellular Carcinoma (HCC)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07703735
- **Lead sponsor:** Seoung Hoon Kim
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2012-01-01
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 371 (ESTIMATED)
- **Last updated:** 2026-07-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07703735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07703735, "Survival and Recurrence After ABO-Incompatible Living Donor Liver Transplantation for Hepatocellular Carcinoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07703735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*